Intimation of appointment of internal auditor for the financial year 2025-2026 as per the regulation 30 of SEBI(LODR)Regulation 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd has informed the stock exchanges about the appointment of an internal auditor for the financial year 2025-2026, in compliance with SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulation 30. This is a routine corporate governance disclosure required of listed companies to ensure proper internal financial controls and audit oversight. The name of the appointed internal auditor has not been highlighted in the headline, suggesting it may be a continuation or standard appointment rather than a notable change. No details about the scope, tenure, or replacement of any prior auditor were mentioned in the headline.
This is a routine compliance filing and is unlikely to have any material impact on the stock price or shareholder interests. It reinforces the company's adherence to regulatory governance norms.